Clinical Trial 44116

Bowling Green, KY 42101


Summary:

Study H8H-MC-LAHV (Study LAHV) will enable a clinical assessment of lasmiditan in a pediatric patient population with migraine for which the medical need is substantial. This study is part of a pediatric clinical program that is intended to provide pivotal efficacy and safety data to support use of lasmiditan for acute treatment of migraine in pediatric patients.


Qualified Participants Must:

• 6-17 years old
• History of migraine attacks for more than 6 months lasting for at least 2 hours


Qualified Participants May Receive:

-No Cost Investigational Medication

-No Cost Study-Related Docotor Visits

-Compensation For Time and Travel


Available At:

Qualmedica Research, LLC
615 7th Ave.
Co-located on 2nd Floor of BGIMP
Bowling Green, KY 42101
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.